Pharmaceutical

CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

HOUSTON, TX / ACCESSWIRE / November 1, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company…

2 months ago

Galecto Reports Third Quarter 2024 Financial Results

-  Completed strategic review to focus on oncology and severe liver diseases -  Announced acquisition of global rights to BRM-1420,…

2 months ago

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

Conference call to be held Monday, November 4, 2024, at 8:30 AM ETNEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) --…

2 months ago

Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024

BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…

2 months ago

iZafe Group Q3 Interim Report, July-September 2024

STOCKHOLM, SE / ACCESSWIRE / November 01, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, November 1,…

2 months ago

Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG

VANCOUVER, BC / ACCESSWIRE / October 31, 2024 / Verisante Technology, Inc. (TSXV:VER.H) ("Verisante") is pleased to announce a transaction…

2 months ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

BOULDER, CO / ACCESSWIRE / October 31, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…

2 months ago

Anju’s Feasibility Flex in TA Scan Wins Best of Show at SCOPE Summit Europe

FORT LAUDERDALE, Fla., Oct. 31, 2024 /PRNewswire/ -- Anju Software recently introduced Feasibility Flex, the newest feature in the flagship…

2 months ago

Water Flosser Market Surges to USD 1,418.81 Million by 2030, Propelled by 5.3% CAGR – Verified Market Reports®

The water flosser market is driven by growing awareness of oral health and hygiene, with consumers increasingly seeking convenient and…

2 months ago

eNavvi and Cost Plus Drugs Expand Relationship to Enhance Prescription Access

LOS ANGELES, Oct. 31, 2024 /PRNewswire/ -- eNavvi, Inc., a leader in the prescription marketplace, and Mark Cuban Cost Plus…

2 months ago